NASDAQ:REPL

Replimune Group Stock Predictions

etoro logo Buy REPL
*Your capital is at risk
$9.98
+1.11 (+12.51%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

REPL Prediction Chart

REPL Predictions History

Latest community submissions for REPL.
Predictor Target Session Target Price Result Direction Accuracy Score
Jun 1, 2026 $8.94 +2.84% $9.00 V 99.30% 4
Jun 1, 2026 $8.36 -3.79% $9.00 X 92.90% 0
Jun 1, 2026 $8.48 -2.37% $9.00 X 94.27% 0
Jun 1, 2026 $15.00 +72.61% $9.00 V 33.33% 1
Apr 6, 2026 $8.20 -2.46% $8.54 X 96.06% 0
Apr 6, 2026 $8.28 -1.54% $8.54 X 96.96% 0
Apr 6, 2026 $8.84 +5.11% $8.54 V 96.49% 1
Oct 29, 2025 $10.11 -3.25% $10.21 V 99.02% 2
Oct 29, 2025 $10.24 -2.03% $10.21 V 99.73% 5
Oct 29, 2025 Bullish $10.21 V 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for REPL with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT REPLIMUNE GROUP INC.
Replimune Group
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes simplex virus 1, which is in Phase I/II clinical trials for a range of solid tumors; and that is in Pha...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE